Reading; Through the Eyes of a University Student
Launched by UNIVERSITY OF ULSTER · Mar 20, 2020
Trial Information
Current as of November 06, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study is checking whether specially tinted glasses (precision tinted lenses) can help reduce visual stress and improve reading for university students who experience these symptoms. It uses a double-masked, randomized crossover design, meaning each participant wears both the “experimental” tint and a similar but non-helpful “control” tint for at least 10 weeks, with a break in between. The order is decided randomly, and neither the participants nor the researchers know which tint is which during the trial.
Who can join? Adults aged 18–45 who are undergraduate students at Ulster University and have visual stress symptoms, with no major vision or eye health problems that could interfere with the study. Exclusions include reduced sharpness of vision, uncorrected glasses prescriptions, certain eye alignment or health issues, and current use of precision tinted lenses. Participants will undergo tests for reading speed and visual symptoms, wear the assigned tinted glasses for the study periods, keep an online diary of symptoms and reading, and be checked again after about three months. The trial is currently enrolling by invitation at Ulster University in Coleraine, with the aim to enroll about 65 people and expected completion in 2025. No results are available yet.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All consenting undergraduate University students, studying at Ulster University who have visual stress symptoms.
- Exclusion Criteria:
- • Reduced visual acuity
- • Uncorrected spectacle prescription
- • Decompensating heterophoria
- • Heterotropia
- • Accommodative insufficiency
- • Convergence insufficiency
- • Ocular health abnormality
- • Any participant currently using precision tinted lenses
About University Of Ulster
The University of Ulster is a leading academic institution dedicated to advancing knowledge and innovation through research and education. Renowned for its commitment to excellence, the university actively engages in clinical trials aimed at improving healthcare outcomes and addressing pressing health challenges. With a robust infrastructure for research and a multidisciplinary approach, the University of Ulster fosters collaboration among researchers, healthcare professionals, and industry partners. Its focus on evidence-based practices ensures that clinical trials are designed and conducted to the highest ethical and scientific standards, contributing valuable insights to the field of medicine and enhancing patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Coleraine, Londonderry, United Kingdom
Coleraine, Londonderry, United Kingdom
Patients applied
Trial Officials
Sara McCullough, PhD
Principal Investigator
Ulster University
Julie-Anne Little, PhD
Study Director
Ulster University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials